Montreal (QUEBEC) – After a year of negotiations, the newly created company Gladius Pharmaceuticals has successfully raised $4,1 million in a Series A financing. In this interview, Michael Atkin, CEO of Gladius, explains how he got in touch with the prestigious investors that participated in the operation, including Lumira Capital, SR One and Fonds de solidarité […]
Montreal (Canada) : This week, Thrasos Therapeutics, headquartered in the NÉOMED Institute, raised a $21 million series D financing lead by BDC Capital, a new investor, and SR One. Other current investors (Advanced Technology Ventures, Fonds de solidarité FTQ, Lumira Capital, MP Healthcare Venture Management, Pappas Ventures and SW Co) also participated in the operation. […]
Montréal (QUEBEC) : 279 M$, c’est une belle somme que vient de prendre en charge Teralys Capital. Cédric Bisson, partner, détaille en avant-première la destination de ce fonds de fonds qui a vocation à être investi dans des sociétés de capital-risque canadiennes et à l’international mais aussi en direct dans des projets novateurs. IT, sciences […]